(Q34043472)
Statements
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events (English)
Christie M Ballantyne
Frederick J Raal
Marc S Sabatine
Stephen D Wiviott
Jennifer Robinson
Ransi Somaratne
Jason Legg
Scott M Wasserman
Michael J Koren
Evan A Stein
Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators